Source: European Parliament
Question for written answer E-002864/2025
to the Commission
Rule 144
Michalis Hadjipantela (PPE)
The promotion of women’s health and fertility rights across the European Union is undoubtedly a core aspect of public health policy and gender equality. The Commission’s 2025 report entitled ‘EU research on advancing women’s health’[1] highlights that over EUR 2 billion has been invested in research related to women’s health under Horizon 2020 and Horizon Europe. Despite this promising investment, chronic conditions such as endometriosis, which affects approximately 1 in 10 women of reproductive age, remain undiagnosed and underfunded in many Member States, including Cyprus.
In Cyprus, women continue to face significant barriers in accessing timely diagnoses and effective treatment for gynaecological conditions such as endometriosis and polycystic ovary syndrome, both of which are linked to fertility issues. Also, public health data collection, awareness campaigns and fertility support services remain limited.
Can the Commission therefore clarify:
- 1.What specific EU funding sources are currently available or planned to support women’s health and fertility, particularly in Cyprus?
- 2.What proportion of this funding targets endometriosis research, treatment and awareness?
- 3.What steps is the Commission taking to ensure that EU-level research and funding are translated into tangible improvements in healthcare provision for women in Cyprus?
Submitted: 14.7.2025
- [1] https://op.europa.eu/en/publication-detail/-/publication/43771686-4a5c-11f0-85ba-01aa75ed71a1/language-en.